These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28506251)

  • 1. Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticus.
    Subramanya SH; Sharan NK; Baral BP; Hamal D; Nayak N; Prakash PY; Sathian B; Bairy I; Gokhale S
    BMC Microbiol; 2017 May; 17(1):113. PubMed ID: 28506251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeasts from Scarlet ibises (Eudocimus ruber): A focus on monitoring the antifungal susceptibility of Candida famata and closely related species.
    Brilhante RSN; Silva ALD; Monteiro FOB; Guedes GMM; Sales JA; Oliveira JS; Maia Junior JE; Miranda SA; Sidrim JJC; Alencar LP; Castelo-Branco DSCM; Cordeiro RA; Pereira Neto WA; Rocha MFG
    Med Mycol; 2017 Oct; 55(7):725-732. PubMed ID: 28204651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity, Virulence Factors, and Antifungal Susceptibility Patterns of Pathogenic and Opportunistic Yeast Species in Rock Pigeon (
    Abulreesh HH; Organji SR; Elbanna K; Osman GEH; Almalki MHK; Abdel-Malek AY; Ghyathuddin AAK; Ahmad I
    Pol J Microbiol; 2019 Dec; 68(4):493-504. PubMed ID: 31880893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E; Erturan Z; Susever S; Yegenoglu Y
    APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC; Chen YH; Chen YC; Lu PL
    Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates.
    Liao Y; Yang S; Cong L; Lu X; Ao J; Yang R
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7615-6. PubMed ID: 25246408
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts.
    Montoya AM; Luna-Rodríguez CE; Gracia-Robles G; Rojas OC; González GM
    Arch Microbiol; 2019 Oct; 201(8):1147-1149. PubMed ID: 31147748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of virulence factors, antifungal resistance with ERG-11 gene among Candida species isolated from pulmonary samples.
    Danis Vijay D; Jayanthi S; Meenakshi N; Meharaj SHS; Sujhithra A; Perumal J
    Microb Pathog; 2019 Dec; 137():103750. PubMed ID: 31536801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
    Cocuaud C; Rodier MH; Daniault G; Imbert C
    J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
    Carrillo-Muñoz AJ; Quindós G; del Valle O; Santos P; Giusiano G; Ezkurra PA; Estivill MD; Casals JB
    Chemotherapy; 2008; 54(1):38-42. PubMed ID: 18073469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
    Kawai A; Yamagishi Y; Mikamo H
    J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
    Gharaghani M; Taghipour S; Zarei Mahmoudabadi A
    Mol Biol Rep; 2020 Nov; 47(11):8903-8909. PubMed ID: 33130966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.
    Córdoba S; Vivot W; Bosco-Borgeat ME; Taverna C; Szusz W; Murisengo O; Isla G; Davel G;
    Rev Argent Microbiol; 2011; 43(3):176-85. PubMed ID: 22430989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.